Jaguar Health Executes Preferred Stock Exchange and Adjourns Annual Meeting

On May 21, 2026, Jaguar Health, Inc. entered into two privately negotiated exchange agreements with Streeterville Capital, LLC. Under these agreements, the company issued an aggregate of 54,222 shares of its common stock in exchange for 7.96 outstanding shares of its Series Q Perpetual Preferred Stock. Specifically, one agreement involved the exchange of 4 shares for 27,247 common shares, and the second involved 3.96 shares for 26,975 common shares. Following the transaction, the exchanged preferred shares were cancelled and retired. Additionally, Jaguar Health announced that it has adjourned its 2026 Annual Meeting of Stockholders, originally called to order on May 22, 2026. The meeting is now scheduled to reconvene on June 2, 2026. This adjournment is intended to provide stockholders with additional information regarding certain proposals in the proxy statement, following discussions with Nasdaq staff. The company plans to file a supplement to its Proxy Statement containing this information prior to the new meeting date.